India's largest generics drug maker Ranbaxy Laboratories reported flat earnings in the June quarter despite strong sales.

TRENTON, N.J. - Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

Glenmark Generics Ltd, a unit of India's Glenmark Pharmaceuticals Ltd, has received the nod from the US Food and Drug Administration (USFDA) for the sale of its generic version of anti-hypertension drug, Trandolapril.

RICHMOND, Va. - Philip Morris USA, the nation's No. 1 tobacco company, said Monday it has ended test markets of Marlboro-branded cigarettes that use a high-technology filter.

India's largest generics durgmaker Rnbaxy Laboratories, which has agreed to become a subsidiary of Japanese drugmaker Daiichi Sankyo for $4.6 billion, pulled off a coup of sorts, announcing it has settled certain patent disputes with Pfizer over its $13 billion blockbuster anti-cholesterol drug...

INDIA - In what is seen as India's biggest acquisition deal in the pharmaceutical sector, Japanese drugmaker Daiichi Sankyo Co. said it has reached an agreement with India's largest generics drugmaker Ranbaxy Laboratories Ltd. which will see the former acquire the latter's majority st...

U.S. senator Charles Grassley asked to scrutinize if the drug maker GlaxoSmithKline Plc withheld safety information that linked its drug Paxil to suicide risk.

Martek Biosciences Corp. said on Wednesday its second quarter net income was $9.2 million or 28 cents a share, surpassing analysts forecasts.

Merck & Co. reported a Phase III trial which studies odanacatib for the treatment of osteoporosis in postmenopausal woman is underway which will include tests for breast and prostate cancer.

NEW YORK - Biopharmaceutical group Favrille Inc. shares slumped near 90 percent on Tuesday after the company said it will stop the development of its lead cancer drug, Specifid, as it failed to meet a strategic goal in a late stage trial.

Avanir Pharmaceuticals shares climbed as the company reported today positive results of its large pharmacokinetic study to identify an alternative dosing formulation of Zenvia, designed to deliver similar efficacy as observed in the first Phase III clinical study in diabetic peripheral neuropathic p...

HONG KONG - The total import value of Chinese herbal medicines rose 11.8% last year to $1.69 billion, with a significant portion consumed locally, a Census & Statistics Department study has found.

Anti-Smoking pill Chantrix from Pfizer Inc. was banned today by the Federal Aviation Administration for its use by pilots and air traffic controlers, after a study showed dangerous side effects.

NEW YORK - Merck & Co. said on Tuesday it agreed to pay $58 million to settle allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks in 29 states, including the District of Columbia.

NEW YORK - Immucor Inc. replied on Tuesday to a warning letter from the Food and Drug Administration that pointed out problems of manufacturing practices in the company.

Natus Medical Inc. developer and manufacturer of medical devices fore newborns said Tuesday it is planning to make a public offering of 3.5 million common shares.

Stryker Corp. said today it will invest $50 million in 2008 to improve its quality systems and compliance at the time it deals with three warning letters from the U.S. Food and Drug Administration.

Mylan Inc. manufacturer of generic pharmaceutical products said on Thursday an extended first quarter loss and a large increase on its revenue triggered by the purchase of Merck KGaA in October.

United Drug Plc, on Tuesday said that its pre-tax profit for the six months ended 31 March 2008 went up 15 per cent to 33.28 million euros. The Irish drug-maker also reported a rise in revenue of 9 per cent to 845.07 million euros.